l-carnitine 330mg Carnicor Tablet Carnicor 330mg 1 Tablet -
Description
UCDs occur in ~1 in 35,000 births, among which OTC deficiency is the most common, with an incidence of 1 in 56,500 births 4
Long-chain fatty acids are first converted to fatty acyl-CoA in the cytosol

This pharmacokinetic advantage has made injectable L-carnitine popular in clinical settings (FDA-approved as Carnitor for carnitine deficiency) and research applications focused on fat metabolism and exercise performance
doi: 10.1046/j.1471-4159.2000.0741426.x

[DOI] [PMC free article] [PubMed] [Google Scholar] 159.Askling J, Linet M, Gridley G, Halstensen TS, Ekstrom K, Ekbom A

Dietary meat, trimethylamine N-Oxide-related metabolites, and Incident Cardiovascular Disease among older adults: the Cardiovascular Health Study
